Clinical Trial Update: Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating konjac-mannan shows improvements in glycemia and other cardiovascular risk factors in individuals with type 2 diabetes and coronary h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• konjac-mannan

Snippet

Sponsor: Unity Health Toronto | Conditions: Type2 Diabetes, Coronary Heart Disease | Phase 2 | Status: COMPLETED